Pharma Mar, S.A. (FRA:PMRA)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Oncology	156.84M
Oncology Growth	-17.96%
Diagnostics	1.19M
Diagnostics Growth	-76.79%
RNAi	121.00K
RNAi Growth	290.32%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Ireland	75.36M
Ireland Growth	-13.17%
France	30.00M
France Growth	72.54%
United States	12.51M
United States Growth	-6.40%
Rest of the European Union	10.90M
Rest of the European Union Growth	-42.40%
Spain	6.93M
Spain Growth	-58.36%
Germany	4.64M
Germany Growth	-69.05%
Italy	4.19M
Italy Growth	-72.40%
Other	13.63M
Other Growth	4.17%